BioSpace News Archive

Compass Therapeutics, Inc. (Nasdaq: CMPX) announced the publication of a peer-reviewed article titled, “A bispecific anti-PD-1 and PD-L1 antibody induces PD-1 cleavage and provides enhanced anti-tumor activity” in the journal OncoImmunology.

Corbus Pharmaceuticals Holdings, Inc., a precision oncology company with a diversified portfolio, announced the appointment of Dr. Dominic Smethurst, MA MRCP, as the Company’s Chief Medical Officer.

NewAmsterdam Pharma Company N.V. announced financial results for the fourth quarter and full year ended December 31, 2023 and provided a corporate update.

Protara Therapeutics, Inc. (Nasdaq: TARA) today announced that management will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference on Wednesday, March 6, 2024 at 9:50 am ET in Boston.

Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies, announced its participation in three upcoming investor conferences.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the completion of the clinical stage of its Phase 1, single ascending dose escalation trial of TNX-1500 (Fc-modified humanized anti-CD40L monoclonal antibody, or mAb)* in healthy volunteers.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Tuesday, March 5, 2024, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and year end 2023 and to highlight recent corporate progress.

Genetic Technologies Limited, is pleased to announce the launch of a wide-reaching customer – targeted digital advertising campaign in the United States.

Cognito Therapeutics announced today it has been selected to present data from an open label extension study evaluating its potential novel therapy, Spectris, in Alzheimer’s Disease (AD), as an oral presentation at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Disease, held March 5-9, 2024 in Lisbon, Portugal.

Rapport Therapeutics, Inc. today announced the appointment of Kathy Wilkinson as Chief People Officer.